JP2020019746A - Viscous antibacterial agent - Google Patents

Viscous antibacterial agent Download PDF

Info

Publication number
JP2020019746A
JP2020019746A JP2018146611A JP2018146611A JP2020019746A JP 2020019746 A JP2020019746 A JP 2020019746A JP 2018146611 A JP2018146611 A JP 2018146611A JP 2018146611 A JP2018146611 A JP 2018146611A JP 2020019746 A JP2020019746 A JP 2020019746A
Authority
JP
Japan
Prior art keywords
silver
antibacterial agent
ethanol
viscous
antibacterial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018146611A
Other languages
Japanese (ja)
Inventor
浩之 稲見
Hiroyuki Inami
浩之 稲見
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osaka Pharmaceutical Co Ltd
Original Assignee
Osaka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osaka Pharmaceutical Co Ltd filed Critical Osaka Pharmaceutical Co Ltd
Priority to JP2018146611A priority Critical patent/JP2020019746A/en
Publication of JP2020019746A publication Critical patent/JP2020019746A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

To provide antibacterial agents that have low skin irritation and exert high antibacterial effect, not only for a few hours immediately after attaching to a user's hand or finger, but also even after for longer time, for viscous antibacterial agents containing ethanol.SOLUTION: Provided is a viscous antibacterial agent containing a silver carrier, ethanol, and a thickening compound, characterized by having a viscosity at 25°C of 0.05 to 100 Pa s, the viscous antibacterial agent containing 0.01 to 2.0% by weight of the silver carrier, 30 to 75% by weight of the ethanol, and 0.15 to 2.0% by weight of the thickening compound.SELECTED DRAWING: Figure 1

Description

本件発明は、使用者の手や指に付着した細菌、カビやウイルス等を死滅させるための粘稠な抗菌剤に関する。   The present invention relates to a viscous antibacterial agent for killing bacteria, molds, viruses, and the like attached to a user's hand or finger.

従来、使用者の手や指に付着した細菌、カビやウイルス等を死滅させるために、有効成分としてエタノールを配合した粘稠な抗菌剤が知られている。   BACKGROUND ART Viscous antibacterial agents containing ethanol as an active ingredient in order to kill bacteria, molds, viruses, and the like attached to the hands and fingers of users have been known.

例えば、特許文献1には、塩化ベンザルコニウム、局方エタノール、カルボキシビニルポリマー、ヒドロキシプロピルメチルセルロースなどを含有し粘度が20,000センチポイズである消毒剤が開示されている。   For example, Patent Document 1 discloses a disinfectant having a viscosity of 20,000 centipoise, which contains benzalkonium chloride, local ethanol, carboxyvinyl polymer, hydroxypropylmethylcellulose, and the like.

特開平6−199700号公報JP-A-6-199700

しかしながら、特許文献1の消毒剤では、使用直後においてはエタノールが十分含有されているために、菌の増殖を抑制する抗菌効果を有するが、使用者の体温や外気温などによって徐々にエタノールが揮発していき、徐々にその抗菌効果が逓減するという課題があった。そして、塩化ベンザルコニウムも抗菌効果を有するところ、エタノールよりも抗菌効果が持続するものの、数時間しか効力が持続しないために、やはり徐々にその抗菌効果が逓減するという課題があった。また、使用者が繰り返し手や指に塗り重ねることで、抗菌成分である塩化ベンザルコニウムが濃縮され、掻痒を伴った皮疹、発赤を伴う小水疱などを示すことも懸念される。   However, the disinfectant of Patent Literature 1 has an antibacterial effect of suppressing bacterial growth because ethanol is sufficiently contained immediately after use, but the ethanol gradually evaporates due to the user's body temperature or external temperature. Then, there was a problem that its antibacterial effect gradually decreased. In addition, benzalkonium chloride also has an antibacterial effect. However, although the antibacterial effect lasts longer than ethanol, the effect lasts for only a few hours, so that the antibacterial effect gradually decreases gradually. In addition, there is a concern that if the user repeatedly coats the hands and fingers, the antibacterial component benzalkonium chloride will be concentrated, and it will cause skin rash accompanied by pruritus, vesicles accompanied by redness, and the like.

そこで、本件発明では、エタノールを含有する粘稠な抗菌剤について、使用者の手や指などに付着させた直後から数時間だけでなく、さらに時間が経過した後であっても皮膚刺激性が低く高い抗菌効果を奏する抗菌剤を提供することを目的とする。   Therefore, in the present invention, the viscous antibacterial agent containing ethanol has a skin irritancy not only several hours immediately after being attached to the user's hand or finger, but also after a further time has passed. An object of the present invention is to provide an antibacterial agent having a low and high antibacterial effect.

〔1〕すなわち、銀担持体と、エタノールと、増粘化合物を、含有する粘稠抗菌剤であって、25℃における粘度が0.05〜100Pa・sであることを特徴とする粘稠抗菌剤である。   [1] That is, a viscous antibacterial agent containing a silver carrier, ethanol, and a thickening compound, wherein the viscosity at 25 ° C. is 0.05 to 100 Pa · s. Agent.

〔2〕そして、前記銀担持体が0.01〜2.0重量%、前記エタノールが30〜75重量%、前記増粘化合物が0.15〜2.0重量%含有されていることを特徴とする前記〔1〕に記載の粘稠抗菌剤である。   [2] And, the silver carrier is 0.01 to 2.0% by weight, the ethanol is 30 to 75% by weight, and the thickening compound is 0.15 to 2.0% by weight. The viscous antibacterial agent according to the above [1].

〔3〕そして、前記増粘化合物が、アクリル酸系化合物又は多糖類であることを特徴とする前記〔1〕又は前記〔2〕に記載の粘稠抗菌剤である。   [3] The viscous antibacterial agent according to [1] or [2], wherein the thickening compound is an acrylic acid compound or a polysaccharide.

〔4〕そして、前記増粘化合物が、カルボキシビニルポリマーであることを特徴とする前記〔1〕から前記〔3〕のいずれかに記載の粘稠抗菌剤である。   [4] The viscous antibacterial agent according to any one of [1] to [3], wherein the thickening compound is a carboxyvinyl polymer.

〔5〕そして、前記銀担持体が、金属銀を表面に担持したリン酸カルシウムであることを特徴とする前記〔1〕から前記〔4〕のいずれかに記載の粘稠抗菌剤である。   [5] The viscous antibacterial agent according to any of [1] to [4], wherein the silver carrier is calcium phosphate having metallic silver supported on the surface.

本件発明によれば、エタノールを含有する粘稠な抗菌剤について、使用者の手や指などに付着させた直後だけでなく、エタノールが揮発する程度の時間が経過した後であっても高い抗菌効果を奏することができる。これにより、緑膿菌や黄色ブドウ球菌、大腸菌など、手指を介して感染するとされる様々な病原性細菌を抑制することで感染症や食中毒を予防する効果も奏する。   According to the present invention, the viscous antibacterial agent containing ethanol has a high antibacterial property not only immediately after being attached to a user's hand or finger, but also after the time for which the ethanol evaporates. The effect can be achieved. This also has the effect of preventing infectious diseases and food poisoning by suppressing various pathogenic bacteria, such as Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli, which are supposed to be transmitted through fingers.

本発明の実施例1〜3の組成物の効力の持続性の試験結果を示す図である。It is a figure which shows the test result of the persistence of the effect of the composition of Examples 1-3 of this invention. 本発明の実施例4〜6の組成物の効力の持続性の試験結果を示す図である。It is a figure which shows the test result of the persistence of the effect of the composition of Examples 4-6 of this invention. 本発明の実施例7〜9の組成物の効力の持続性の試験結果を示す図である。It is a figure which shows the test result of the persistence of the effect of the composition of Examples 7-9 of this invention. 本発明の比較例1及び3の組成物の効力の持続性の試験結果を示す図である。It is a figure which shows the test result of the persistence of the effect of the composition of the comparative examples 1 and 3 of this invention.

以下、本件発明の粘稠抗菌剤に関する実施形態について詳しく説明する。なお、説明中における範囲を示す表記のある場合は、上限と下限を含有するものである。   Hereinafter, embodiments of the viscous antibacterial agent of the present invention will be described in detail. In addition, when there is a notation indicating the range in the description, it includes the upper limit and the lower limit.

本件発明における銀担持体は、金属銀、銀イオン、銀塩など銀の原子を担持している化合物であり、溶出した銀イオンが、細菌、カビやウイルスの細胞内に入り込み酵素の働きを阻害や不活化するなどして抗菌効果を奏する有効成分である。   The silver carrier in the present invention is a compound that supports silver atoms such as metallic silver, silver ions, and silver salts, and the eluted silver ions enter the cells of bacteria, molds and viruses and inhibit the function of enzymes. It is an active ingredient that exerts an antibacterial effect by inactivating or inactivating it.

銀塩としては、例えば、酢酸銀、アセチルアセトン酸銀、アジ化銀、銀アセチリド、ヒ酸銀、安息香酸銀、フッ化水素銀、臭素酸銀、臭化銀、炭酸銀、塩化銀、塩素酸銀、クロム酸銀、クエン酸銀、シアン酸銀、シアン化銀、(cis,cis−1,5−シクロオクタジエン)−1,1,1,5,5,5−ヘキサフルオロアセチルアセトン酸銀、ジエチルジチオカルバミン酸銀、フッ化銀(I)、フッ化銀(II)、7,7−ジメチル−1,1,1,2,2,3,3−ヘプタフルオロ−4,6−オクタンジオン酸銀、ヘキサフルオロアンチモン酸銀、ヘキサフルオロヒ酸銀、ヘキサフルオロリン酸銀、ヨウ素酸銀、ヨウ化銀、イソチオシアン酸銀、シアン化銀カリウム、乳酸銀、モリブデン酸銀、硝酸銀、亜硝酸銀、酸化銀(I)、酸化銀(II)、シュウ酸銀、過塩素酸銀、ペルフルオロ酪酸銀、ペルフルオロプロピオン酸銀、過マンガン酸銀、過レニウム酸銀、リン酸銀、ピクリン酸銀一水和物、プロピオン酸銀、セレン酸銀、セレン化銀、亜セレン酸銀、スルファジアジン銀、硫酸銀、硫化銀、亜硫酸銀、テルル化銀、テトラフルオロ硼酸銀、テトラヨードムキュリウム酸銀、テトラタングステン酸銀、チオシアン酸銀、p−トルエンスルホン酸銀、トリフルオロメタンスルホン酸銀、トリフルオロ酢酸銀、バナジン酸銀等や、ヒスチジン銀錯体、メチオニン銀錯体、システイン銀錯体、アスパラギン酸銀錯体、ピロリドンカルボン酸銀錯体、オキソテトラヒドロフランカルボン酸銀錯体、イミダゾール銀錯体などが好ましい。   Examples of the silver salt include silver acetate, silver acetylacetonate, silver azide, silver acetylide, silver arsenate, silver benzoate, silver hydrogen fluoride, silver bromate, silver bromide, silver carbonate, silver chloride, and chloric acid. Silver, silver chromate, silver citrate, silver cyanate, silver cyanide, silver (cis, cis-1,5-cyclooctadiene) -1,1,1,5,5,5-hexafluoroacetylacetonate; Silver diethyldithiocarbamate, silver (I) fluoride, silver (II) fluoride, silver 7,7-dimethyl-1,1,1,2,2,3,3-heptafluoro-4,6-octanedionate , Silver hexafluoroantimonate, silver hexafluoroarsenate, silver hexafluorophosphate, silver iodate, silver iodide, silver isothiocyanate, potassium silver cyanide, silver lactate, silver molybdate, silver nitrate, silver nitrite, silver oxide (I), silver oxide ( I), silver oxalate, silver perchlorate, silver perfluorobutyrate, silver perfluoropropionate, silver permanganate, silver perrhenate, silver phosphate, silver picrate monohydrate, silver propionate, silver selenate , Silver selenide, silver selenite, silver sulfadiazine, silver sulfate, silver sulfide, silver sulfite, silver telluride, silver tetrafluoroborate, silver tetraiodomuccurate, silver tetratungstate, silver thiocyanate, p-toluene Silver sulfonate, silver trifluoromethanesulfonate, silver trifluoroacetate, silver vanadate, etc., silver histidine complex, silver methionine complex, silver cysteine complex, silver aspartate complex, silver pyrrolidonecarboxylate complex, silver oxotetrahydrofurancarboxylate complex And an imidazole silver complex.

銀を担持している担体としては、リン酸亜鉛カルシウム、リン酸カルシウム、リン酸ジルコニウム、リン酸アルミニウム、ケイ酸カルシウム、活性炭、活性アルミナ、シリカゲル、ゼオライト、ヒドロキシアパタイト、リン酸ジルコニウム、リン酸チタン、チタン酸カリウム、含水酸化ビスマス、含水酸化ジルコニウム、ハイドロタルサイトなどの無機化合物や銀イオンとキレート錯体を形成可能なアミノ酸などの有機化合物が好ましい。   Examples of the carrier supporting silver include zinc calcium phosphate, calcium phosphate, zirconium phosphate, aluminum phosphate, calcium silicate, activated carbon, activated alumina, silica gel, zeolite, hydroxyapatite, zirconium phosphate, titanium phosphate, and titanium. Inorganic compounds such as potassium acid, bismuth hydroxide, zirconium hydroxide and hydrotalcite, and organic compounds such as amino acids capable of forming a chelate complex with silver ions are preferred.

本件発明の粘稠抗菌剤における銀担持体の配合割合としては、0.01〜2.0重量%が好ましく、0.05〜1.5重量%がより好ましい。銀担持体の配合割合が、この範囲にあると、使用者の手や指などに塗布したのちにエタノールが揮発するくらいの時間が経過しても銀担持体に含まれる銀は使用者の体温や外気温によって揮発することがないために、抗菌効果を持続させることができ、また、銀担持体が凝集して沈殿することなく粘稠抗菌剤中に均一に分散するために、いつ使用しても安定した抗菌効果を奏することができる。また、銀担持体は、皮膚刺激性がほとんどないため、使用者が本件発明の粘稠抗菌剤を繰り返し手や指に塗り重ねたとしても炎症などを示すおそれがほとんどない。   The mixing ratio of the silver carrier in the viscous antibacterial agent of the present invention is preferably 0.01 to 2.0% by weight, and more preferably 0.05 to 1.5% by weight. When the compounding ratio of the silver carrier is within this range, the silver contained in the silver carrier remains at the body temperature of the user even after the time that the ethanol evaporates after the application to the user's hand or finger. The antibacterial effect can be sustained because it does not volatilize due to heat or outside temperature, and it is used when the silver carrier is uniformly dispersed in the viscous antibacterial agent without aggregation and precipitation. However, a stable antibacterial effect can be achieved. Further, since the silver carrier has little skin irritation, there is almost no risk of irritation or the like even if the user repeatedly applies the viscous antibacterial agent of the present invention to hands or fingers.

本件発明におけるエタノールは、菌の生育を阻み、また、菌を死滅させる抗菌効果を奏する有効成分である。   Ethanol in the present invention is an active ingredient that has an antibacterial effect that inhibits the growth of bacteria and kills the bacteria.

本件発明の粘稠抗菌剤におけるエタノールの含有割合は、30〜75重量%が好ましく、55〜65重量%がさらに好ましい。エタノールの含有割合がこの範囲にあると、菌などの増殖の抑制及び死滅などの抗菌効果を有するとともに、増粘化合物を均一に分散することができる。   The content of ethanol in the viscous antibacterial agent of the present invention is preferably 30 to 75% by weight, more preferably 55 to 65% by weight. When the content ratio of ethanol is in this range, it has an antibacterial effect such as suppression of growth and death of bacteria and the like, and can uniformly disperse the thickening compound.

本件発明における増粘化合物は、抗菌剤の粘性を向上させるための化合物である。具体的には、アクリル酸系化合物や多糖類が用いられることが好ましい。アクリル酸系化合物としては、カルボキシビニルポリマー、ポリアクリル酸ナトリウムなどが好ましい。多糖類としては、ヒドロキシエチル基が導入されたセルロース誘導体であるヒドロキシエチルセルロース、ヒドロキシプロピル基が導入されたセルロース誘導体であるヒドロキシプロピルセルロース、ヒドロキシプロピル基及び低級アルキル基のうちメチル基が導入されたセルロース誘導体であるヒドロキシプロピルメチルセルロース、ヒドロキシプロピルメチルセルロースにステアリルグリシジルエーテルなどの疎水性のアルキル基を有するグリシジルエーテルを反応させて得られる疎水化ヒドロキシプロピルメチルセルロース、ヒドロキシエチル基及びヒドロキシプロピル基が導入されたセルロースであるヒドロキシエチルヒドロキシプロピルセルロース、カルボキシメチル基が導入されたセルロースの塩であるカルボキシメチルセルロースナトリウム、キサンタンガム、アルギン酸ナトリウムなどが好ましい。また、疎水化ヒドロキシプロピルメチルセルロースにおいては、疎水基がステアリル基だけでなく炭素数6〜22などの中鎖及び長鎖アルキル基を用いることもできる。なお、導入されるヒドロキシエチル基及びヒドロキシプロピル基は、セルロース中の水酸基1つに対して1または複数付加することができ、1〜10付加されていることが好ましい。特に、カルボキシビニルポリマーを用いることにより、銀担持体を均一に分散させることができるだけでなく、長期間保存したときにも抗菌剤が黒く変色することを抑制することができる点において好適である。   The thickening compound in the present invention is a compound for improving the viscosity of the antibacterial agent. Specifically, it is preferable to use an acrylic acid compound or a polysaccharide. As the acrylic acid compound, a carboxyvinyl polymer, sodium polyacrylate and the like are preferable. Polysaccharides include hydroxyethyl cellulose which is a cellulose derivative having a hydroxyethyl group introduced, hydroxypropyl cellulose which is a cellulose derivative having a hydroxypropyl group introduced, and cellulose having a methyl group introduced among hydroxypropyl and lower alkyl groups. Hydroxypropyl methylcellulose which is a derivative, hydrophobized hydroxypropylmethylcellulose obtained by reacting glycidyl ether having a hydrophobic alkyl group such as stearyl glycidyl ether with hydroxypropylmethylcellulose, cellulose in which hydroxyethyl group and hydroxypropyl group are introduced. Certain hydroxyethyl hydroxypropyl cellulose, carboxymethyl cellulose which is a salt of cellulose having a carboxymethyl group introduced Scan sodium, xanthan gum, and sodium alginate are preferable. In the hydrophobized hydroxypropylmethylcellulose, not only a stearyl group but also a medium-chain or long-chain alkyl group having 6 to 22 carbon atoms can be used. One or more hydroxyethyl groups and hydroxypropyl groups can be added to one hydroxyl group in cellulose, and preferably 1 to 10 are added. In particular, the use of a carboxyvinyl polymer is preferable in that not only can the silver carrier be uniformly dispersed, but also the antibacterial agent can be prevented from discoloring black when stored for a long period of time.

本件発明の粘稠抗菌剤における増粘化合物の含有割合は、0.15〜2.0重量%が好ましく、0.2〜1.5重量%がさらに好ましい。増粘化合物の含有割合がこの範囲にあると、抗菌剤中に銀担持体を均一に分散することができ、また、抗菌剤を使用者が手や指などに付着させてもただちに流れ落ちることなく、また、塗り広げるときにものばしやすいとともに、べたつきを感じさせないという効果を奏する。   The content ratio of the thickening compound in the viscous antibacterial agent of the present invention is preferably 0.15 to 2.0% by weight, more preferably 0.2 to 1.5% by weight. When the content of the thickening compound is within this range, the silver carrier can be uniformly dispersed in the antibacterial agent, and the antibacterial agent does not immediately flow off even if the user attaches it to the hand or finger. In addition, it has the effect of making it easy to spread when spreading, and not giving any stickiness.

増粘化合物を配合することにより抗菌剤の粘度は向上するところ、各種成分を配合して攪拌し均一な白色な溶液となった状態におけるその抗菌剤の粘度はJIS K7117−1に記載のブルックフィールド形回転粘度計B形(東機産業株式会社製、商品名「TVB−10M」)を用いた計測において、25℃条件下0.05〜100Pa・sであることが好ましく、50〜5000mPa・sであることがさらに好ましく、100〜3000mPa・sであることがもっとも好ましい。粘度がこの範囲にあると、抗菌液を手などの肌に付着してもただちに流れ落ちることなく、また、塗り広げるときにものばしやすい。   Although the viscosity of the antibacterial agent is improved by compounding the thickening compound, the viscosity of the antibacterial agent in the state of mixing and stirring various components to form a uniform white solution is determined by Brookfield described in JIS K7117-1. In a measurement using a rotary viscometer type B (manufactured by Toki Sangyo Co., Ltd., trade name “TVB-10M”), the pressure is preferably 0.05 to 100 Pa · s at 25 ° C., and 50 to 5000 mPa · s. Is more preferable, and most preferably 100 to 3000 mPa · s. When the viscosity is in this range, even if the antibacterial liquid adheres to the skin such as hands, the antibacterial liquid does not run off immediately and is easy to spread when spread.

本件発明の粘稠抗菌剤において、水を配合することもできる。配合する水としては、日本薬局方規格の水が好ましく、例えば、水道水、井戸水などである常水、そして、蒸留、イオン交換膜によるイオン交換処理、限外ろ過膜による限外ろ過処理のいずれか、またはそれらの組み合わせにより常水を処理した精製水、そして、加熱等により精製水を滅菌処理した滅菌精製水などが好ましい。水の含有割合は、20〜50重量%であることが好ましい。   In the viscous antibacterial agent of the present invention, water can be blended. The water to be blended is preferably water of the Japanese Pharmacopoeia standard, for example, tap water, ordinary water such as well water, and any of distillation, ion exchange treatment with an ion exchange membrane, and ultrafiltration treatment with an ultrafiltration membrane Alternatively, purified water obtained by treating ordinary water with a combination thereof, and sterilized purified water obtained by sterilizing purified water by heating or the like are preferable. The water content is preferably 20 to 50% by weight.

本件発明の粘稠抗菌剤のpHが、25℃において2〜7であることが好ましく、3〜6であることがさらに好ましい。本件発明の粘稠抗菌剤のpHが上記範囲にあると、エタノールや銀担持体の有効成分だけでなく、液性によっても酸性領域に耐性がない多くの菌に対して、抗菌効果を奏することができる。また、増粘化合物として、カルボキシビニルポリマー、ポリアクリル酸ナトリウムなどのアクリル酸系化合物を用いた場合には、分子鎖が広がり増粘することが可能となる。本件発明の粘稠抗菌剤のpHを調整するために、クエン酸、グルコン酸、コハク酸、炭酸カリウム、炭酸水素ナトリウム、トリエタノールアミンなどのpH調整剤を添加することができる。   The pH of the viscous antibacterial agent of the present invention is preferably 2 to 7 at 25 ° C, more preferably 3 to 6. When the pH of the viscous antibacterial agent of the present invention is within the above range, the viscous antibacterial agent exhibits an antibacterial effect not only on the active ingredients of ethanol and the silver carrier, but also on many bacteria that are not resistant to the acidic region even by liquidity. Can be. When an acrylic acid compound such as a carboxyvinyl polymer or sodium polyacrylate is used as the thickening compound, the molecular chain can be expanded and the viscosity can be increased. In order to adjust the pH of the viscous antibacterial agent of the present invention, a pH adjuster such as citric acid, gluconic acid, succinic acid, potassium carbonate, sodium hydrogencarbonate, and triethanolamine can be added.

本件発明の粘稠抗菌剤には、上記した成分の他に、必要に応じて、グリセリン、プロピレングリコール、ブチレングリコール、ソルビットなどの保湿剤である多価アルコール、炭酸塩などの発泡剤、非イオン性・アニオン性・カチオン性などの界面活性剤、BHTなどの抗酸化剤、緩衝剤、香料、色素などを配合することもできる。   In the viscous antibacterial agent of the present invention, in addition to the above-mentioned components, if necessary, glycerin, propylene glycol, butylene glycol, humectants such as polyhydric alcohols such as sorbit, foaming agents such as carbonates, nonionic A surfactant such as anionic, anionic, or cationic, an antioxidant such as BHT, a buffer, a fragrance, a dye, and the like can also be blended.

以下、本件発明の実施例について具体的に説明する。なお、本件発明は以下の実施例に限定されるものではない。また、数値範囲を示す表現は、上限及び下限を含有する。   Hereinafter, embodiments of the present invention will be specifically described. The present invention is not limited to the following embodiments. Further, expressions indicating numerical ranges include upper and lower limits.

<実施例1>
容量が200mlのグリフィンビーカーに、エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてカルボキシビニルポリマーを0.6g、精製水を38.6g加え、pH調整剤としてトリエタノールアミンを少量滴下し、均一な白色の溶液になるまで攪拌し、合計100gの抗菌剤を得た。
<Example 1>
To a Griffin beaker having a capacity of 200 ml, 60.7 g of ethanol, 0.1 g of calcium phosphate supporting metallic silver as a silver carrier, 0.6 g of a carboxyvinyl polymer as a thickening compound, and 38.6 g of purified water were added, and a pH adjuster was added. , A small amount of triethanolamine was added dropwise, and the mixture was stirred until a uniform white solution was obtained, thereby obtaining a total of 100 g of an antibacterial agent.

<実施例2>
エタノールを60.4g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてヒドロキシエチルセルロースを1.1g、精製水を38.4g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 2>
Example 1 was repeated except that 60.4 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 1.1 g of hydroxyethyl cellulose as a thickening compound, 38.4 g of purified water, and an appropriate amount of a pH adjuster were added. A total of 100 g of the antibacterial agent was obtained in the same manner as in the above.

<実施例3>
エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてヒドロキシプロピルセルロースを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 3>
Example 1 except that 60.7 g of ethanol, 0.1 g of calcium phosphate carrying metal silver as a silver carrier, 0.6 g of hydroxypropyl cellulose as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster were added. As in Example 1, a total of 100 g of the antibacterial agent was obtained.

<実施例4>
エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてヒドロキシプロピルメチルセルロースを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 4>
Example 1 except that 60.7 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.6 g of hydroxypropylmethylcellulose as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster were added. As in Example 1, a total of 100 g of the antibacterial agent was obtained.

<実施例5>
エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物として疎水化ヒドロキシプロピルメチルセルロースを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 5>
Except for adding 60.7 g of ethanol, 0.1 g of calcium phosphate carrying metal silver as a silver carrier, 0.6 g of hydrophobized hydroxypropylmethylcellulose as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster, As in Example 1, a total of 100 g of the antibacterial agent was obtained.

<実施例6>
エタノールを60.7g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてポリアクリル酸ナトリウムを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 6>
Except that 60.7 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.6 g of sodium polyacrylate as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster were added. As in Example 1, a total of 100 g of the antibacterial agent was obtained.

<実施例7>
エタノールを60.9g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてアルギン酸ナトリウムを0.2g、精製水を38.8g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 7>
Example 1 except that 60.9 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.2 g of sodium alginate as a thickening compound, 38.8 g of purified water, and an appropriate amount of a pH adjuster were added. A total of 100 g of the antibacterial agent was obtained in the same manner as in the above.

<実施例8>
エタノールを60.9g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてカルボキシメチルセルロースナトリウムを0.2g、精製水を38.8g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 8>
Example 1 except that 60.9 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.2 g of sodium carboxymethylcellulose as a thickening compound, 38.8 g of purified water, and an appropriate amount of a pH adjuster were added. As in Example 1, a total of 100 g of the antibacterial agent was obtained.

<実施例9>
エタノールを60.9g、銀担持体として金属銀担持リン酸カルシウムを0.1g、増粘化合物としてキサンタンガムを0.2g、精製水を38.8g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Example 9>
Example 1 was the same as Example 1 except that 60.9 g of ethanol, 0.1 g of calcium phosphate supporting metal silver as a silver carrier, 0.2 g of xanthan gum as a thickening compound, 38.8 g of purified water, and an appropriate amount of a pH adjuster were added. Similarly, a total of 100 g of the antibacterial agent was obtained.

<比較例1>
エタノールを60.8g、増粘化合物としてカルボキシビニルポリマーを0.6g、精製水を38.7g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Comparative Example 1>
A total of 100 g of an antibacterial agent was obtained in the same manner as in Example 1, except that 60.8 g of ethanol, 0.6 g of carboxyvinyl polymer as a thickening compound, 38.7 g of purified water, and an appropriate amount of a pH adjuster were added.

<比較例2>
エタノールを61.0g、銀担持体として金属銀担持リン酸カルシウムを0.1g、精製水を38.8g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Comparative Example 2>
A total of 100 g of an antibacterial agent was obtained in the same manner as in Example 1, except that 61.0 g of ethanol, 0.1 g of calcium phosphate carrying metal silver as a silver carrier, 38.8 g of purified water, and an appropriate amount of a pH adjuster were added. .

<比較例3>
エタノールを60.7g、塩化ベンザルコニウムを0.1g、増粘化合物としてカルボキシビニルポリマーを0.6g、精製水を38.6g、pH調整剤を適量加えた以外は、実施例1と同様に合計100gの抗菌剤を得た。
<Comparative Example 3>
Same as Example 1 except that 60.7 g of ethanol, 0.1 g of benzalkonium chloride, 0.6 g of carboxyvinyl polymer as a thickening compound, 38.6 g of purified water, and an appropriate amount of a pH adjuster were added. A total of 100 g of the antibacterial agent was obtained.

上記の抗菌剤の評価方法については、以下の方法で確認した。   The evaluation method of the above antibacterial agent was confirmed by the following method.

〔外観〕
外観について、配合した抗菌剤を24時間静置し目視にて確認した。黒っぽい変色や沈殿物が無いものを○と評価し、変色や沈殿物がわずかに生じているときは△と評価し、変色、沈殿物が大きく生じているときは×と評価した。これらのうち、○及び△を良好、×を不良と判断した。
〔appearance〕
About the appearance, the compounded antibacterial agent was allowed to stand for 24 hours and visually checked. Those with no dark discoloration or sediment were evaluated as ○, when discoloration or sediment was slightly generated, evaluated as Δ, and when discoloration or sediment was largely generated, evaluated as x. Among these, ○ and Δ were judged as good, and × was judged as bad.

〔pH〕
pHについて、pH7(中性リン酸塩)標準液(pH 6.86 at 25℃)をゼロ点とし、pH4(フタル酸塩)標準液(pH 4.01 at 25℃)またはpH9(ホウ酸塩)標準液(pH 9.18 at 25℃)で校正したpH測定器(株式会社堀場製作所製、商品名F-52)を用いて、25℃に補正した値として測定した。
[PH]
With respect to pH, a pH 7 (neutral phosphate) standard solution (pH 6.86 at 25 ° C.) was set to zero, and a pH 4 (phthalate) standard solution (pH 4.01 at 25 ° C.) or pH 9 (borate) was used. ) Using a pH measuring device (F-52, manufactured by Horiba, Ltd.) calibrated with a standard solution (pH 9.18 at 25 ° C.), the value was measured as a value corrected to 25 ° C.

〔粘度〕
上記の抗菌剤を容器に入れて25℃の恒温槽にて静置して、上記の抗菌剤が25℃になってからJIS K7117−1に記載のブルックフィールド形回転粘度計B形(東機産業株式会社製、商品名「TVB−10M」)にローター(No.20)を取り付けて計測した。
〔viscosity〕
The above-mentioned antibacterial agent was put in a container and allowed to stand in a constant temperature bath at 25 ° C., and after the above-mentioned antibacterial agent reached 25 ° C., a Brookfield-type rotational viscometer B type described in JIS K7117-1 (Toki Machine Co., Ltd.) The measurement was performed by attaching a rotor (No. 20) to a trade name “TVB-10M” manufactured by Sangyo Co., Ltd.).

〔使用感〕
使用感について、配合した抗菌剤を掌に滴下して塗り広げたときの官能により評価した。掌からこぼれ落ちにくく、糊状の剥離物であるヨレが生じたり、べたついたりすることのないものを○と評価し、多少掌からこぼれ落ち、ヨレやべたつきを感じる物を△と評価し、掌からこぼれ落ちやすく、明らかにヨレやべたつきを感じる物を×と評価した。これらのうち、○及び△を良好、×を不良と判断した。これらの結果を表1に併せて示す。
(Usability)
The feeling of use was evaluated based on the organoleptic effect when the compounded antibacterial agent was dropped on the palm and spread. Those that are hard to spill from the palm and do not produce sticky peels or sticky are evaluated as ○, and those that spill slightly from the palm and feel swelling or sticky are evaluated as △, and spilled from the palm Those which were easy and clearly felt stickiness and stickiness were evaluated as x. Among these, ○ and Δ were judged as good, and × was judged as bad. The results are shown in Table 1.

〔効力の持続性〕
流水にて手洗いを行った後、ハンドスタンプ培地(SCD培地)に掌を押し付け、消毒 前の菌を採取した。次に配合した抗菌剤約2gを手に擦りこみ、乾燥させた後ハンドス タンプ培地に掌を押し付け、塗布直後の菌を採取した。その後、滅菌済みグローブを装 着し3時間後及び6時間後にグローブをはずしてハンドスタンプ培地に掌を押し付け、 菌を採取した。これらのハンドスタンプ培地を約35℃の恒温槽にて約24時間以上培 養し,生菌数(cfu:コロニー形成単位)を測定した。3時間後、6時間後菌数が消毒 前よりも低く、抗菌効果が維持できているものを○と評価し、3時間後、6時間後菌数 が消毒前よりも増加し抗菌効果が維持できていないもの×と評価した。これらのうち、 ○を良好、×を不良と判断した。これらの結果を図1〜4と表1に示す。
(Persistence of efficacy)
After hand washing with running water, the palm was pressed against a hand-stamp medium (SCD medium) to collect the bacteria before disinfection. Next, about 2 g of the compounded antibacterial agent was rubbed in the hand and dried, and then the palm was pressed against a hand stamp medium to collect the bacteria immediately after application. Then, after 3 hours and 6 hours after the sterilized gloves were attached, the gloves were removed and the palm was pressed against the hand-stamp medium to collect the bacteria. The hand-stamped medium was cultured in a thermostat at about 35 ° C. for about 24 hours or more, and the viable cell count (cfu: colony forming unit) was measured. After 3 hours and 6 hours, the number of bacteria was lower than before the disinfection and the antibacterial effect was maintained, and the sample was evaluated as ○. After 3 hours and 6 hours, the number of bacteria increased compared to before the disinfection and the antibacterial effect was maintained. It was evaluated as x which could not be made. Among these, ○ was judged as good and X was judged as bad. These results are shown in FIGS.

これらの実施例1〜9、比較例1〜3の組成及び試験結果を表1にまとめて示す。   Table 1 shows the compositions and test results of Examples 1 to 9 and Comparative Examples 1 to 3.

Figure 2020019746
Figure 2020019746

表1に示すように、実施例1〜9の抗菌剤において、銀担持体を添加しても沈殿や変色することなく均一な白色の液となり、手指に塗り広げたときに掌からこぼれ落ちにくく、糊状の剥離物であるヨレが生じたり、べたついたりすることのない良好な使用感とすることができ、さらに、所定時間経過後であっても抗菌効果を持続することができた。また、所定時間経過後であっても、塗広げた箇所に刺激性を感じることはなかった。   As shown in Table 1, in the antibacterial agents of Examples 1 to 9, even when a silver carrier was added, the solution became a uniform white liquid without precipitation or discoloration, and hardly spilled from the palm when spread on fingers. A good feeling of use without sticking or sticking as a paste-like peeled product was obtained, and the antibacterial effect could be maintained even after a lapse of a predetermined time. Further, even after the elapse of the predetermined time, no irritation was felt in the spread area.

Claims (5)

銀担持体と、
エタノールと、
増粘化合物を含有する粘稠抗菌剤であって、
25℃における粘度が0.05〜100Pa・sであることを特徴とする粘稠抗菌剤。
A silver carrier;
Ethanol and
A viscous antibacterial agent containing a thickening compound,
A viscous antibacterial agent having a viscosity at 25 ° C. of 0.05 to 100 Pa · s.
前記銀担持体が0.01〜2.0重量%、
前記エタノールが30〜75重量%、
前記増粘化合物が0.15〜2.0重量%含有されていることを特徴とする請求項1に記載の粘稠抗菌剤。
0.01 to 2.0% by weight of the silver carrier;
30 to 75% by weight of the ethanol,
The viscous antibacterial agent according to claim 1, wherein the thickening compound is contained in an amount of 0.15 to 2.0% by weight.
前記増粘化合物が、アクリル酸系化合物又は多糖類であることを特徴とする請求項1又は請求項2に記載の粘稠抗菌剤。 The viscous antibacterial agent according to claim 1 or 2, wherein the thickening compound is an acrylic acid compound or a polysaccharide. 前記増粘化合物が、カルボキシビニルポリマーであることを特徴とする請求項1から請求項3のいずれかに記載の粘稠抗菌剤。 The viscous antibacterial agent according to any one of claims 1 to 3, wherein the thickening compound is a carboxyvinyl polymer. 前記銀担持体が、金属銀を表面に担持したリン酸カルシウムであることを特徴とする請求項1から請求項4のいずれかに記載の粘稠抗菌剤。 The viscous antibacterial agent according to any one of claims 1 to 4, wherein the silver carrier is calcium phosphate having metallic silver supported on the surface.
JP2018146611A 2018-08-03 2018-08-03 Viscous antibacterial agent Pending JP2020019746A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2018146611A JP2020019746A (en) 2018-08-03 2018-08-03 Viscous antibacterial agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018146611A JP2020019746A (en) 2018-08-03 2018-08-03 Viscous antibacterial agent

Publications (1)

Publication Number Publication Date
JP2020019746A true JP2020019746A (en) 2020-02-06

Family

ID=69589125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018146611A Pending JP2020019746A (en) 2018-08-03 2018-08-03 Viscous antibacterial agent

Country Status (1)

Country Link
JP (1) JP2020019746A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021224481A1 (en) * 2020-05-07 2021-11-11 Giger & Klingler Ag Hand sanitizer
JP2022045264A (en) * 2020-09-08 2022-03-18 信越化学工業株式会社 Alcohol composition
WO2022163694A1 (en) * 2021-01-29 2022-08-04 花王株式会社 Composition for external application
WO2022249748A1 (en) * 2021-05-24 2022-12-01 住友精化株式会社 Gel composition
JP7361004B2 (en) 2020-09-08 2023-10-13 信越化学工業株式会社 Method for producing alcohol composition

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03218765A (en) * 1989-11-14 1991-09-26 Sangi:Kk Antimicrobial ceramics material
JPH06199700A (en) * 1992-12-28 1994-07-19 Toko Yakuhin Kogyo Kk Quick-drying gel-type disinfectant for finger
JPH06271472A (en) * 1992-10-14 1994-09-27 Matsushita Electric Ind Co Ltd Antiviral composition and its production
JPH0892078A (en) * 1994-09-16 1996-04-09 Osaka Seiyaku:Kk Disinfectant composition
JP2008143878A (en) * 2006-12-13 2008-06-26 Kawamoto Sangyo Kk Disinfectant composition for digiti manus
JP2010163419A (en) * 2008-12-16 2010-07-29 Kao Corp Hand disinfectant composition
JP2012144481A (en) * 2011-01-12 2012-08-02 Kao Corp Finger disinfectant composition
JP2013515679A (en) * 2009-12-24 2013-05-09 パーレン コンヴァーティング アクチェンゲゼルシャフト Antifungal material
WO2016020168A1 (en) * 2014-08-06 2016-02-11 Unilever N.V. A process for preparing an antimicrobial particulate composition

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03218765A (en) * 1989-11-14 1991-09-26 Sangi:Kk Antimicrobial ceramics material
JPH06271472A (en) * 1992-10-14 1994-09-27 Matsushita Electric Ind Co Ltd Antiviral composition and its production
JPH06199700A (en) * 1992-12-28 1994-07-19 Toko Yakuhin Kogyo Kk Quick-drying gel-type disinfectant for finger
JPH0892078A (en) * 1994-09-16 1996-04-09 Osaka Seiyaku:Kk Disinfectant composition
JP2008143878A (en) * 2006-12-13 2008-06-26 Kawamoto Sangyo Kk Disinfectant composition for digiti manus
JP2010163419A (en) * 2008-12-16 2010-07-29 Kao Corp Hand disinfectant composition
JP2013515679A (en) * 2009-12-24 2013-05-09 パーレン コンヴァーティング アクチェンゲゼルシャフト Antifungal material
JP2012144481A (en) * 2011-01-12 2012-08-02 Kao Corp Finger disinfectant composition
WO2016020168A1 (en) * 2014-08-06 2016-02-11 Unilever N.V. A process for preparing an antimicrobial particulate composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021224481A1 (en) * 2020-05-07 2021-11-11 Giger & Klingler Ag Hand sanitizer
JP2022045264A (en) * 2020-09-08 2022-03-18 信越化学工業株式会社 Alcohol composition
JP7361004B2 (en) 2020-09-08 2023-10-13 信越化学工業株式会社 Method for producing alcohol composition
WO2022163694A1 (en) * 2021-01-29 2022-08-04 花王株式会社 Composition for external application
WO2022249748A1 (en) * 2021-05-24 2022-12-01 住友精化株式会社 Gel composition

Similar Documents

Publication Publication Date Title
JP2020019746A (en) Viscous antibacterial agent
CN109381480B (en) Compound polyhexamethylene biguanide disinfectant and preparation method thereof
CN101646342B (en) Disinfectant
CN106942271B (en) A kind of compound potassium hydrogen persulfate disinfectant and preparation method thereof
KR100437566B1 (en) Disinfectant composition comprising alcohol, chlorhexidine and an organic acid
US5916882A (en) Povidone iodine (PVP-I) alcohol gel antimicrobial pre-operative skin preparation
US8940792B2 (en) Antimicrobial composition and methods for using same
CN102470148B (en) Silver oxide formulations having improved whiteness characteristics
CN108566954A (en) A kind of disinfectant and its preparation method and application
JP2012072134A (en) Silver ion production liquid for antibacterial use, silver ion antibacterial liquid produced from the liquid, and production method for producing the antibacterial liquid
WO1997029742A1 (en) Lubricating and/or germicidal composition
CN108042562A (en) Disposable disinfectant of the compound alcohol of gel-type and preparation method thereof
CN111165478A (en) Foam type sterilization, disinfection and air purification agent and preparation method and application thereof
CN111467283A (en) Disinfectant gel and preparation method thereof
JP7058490B2 (en) Antibacterial composition that suppresses viruses, bacteria and fungi
JPH11349418A (en) Viscous quick-drying germicidal disinfectant
WO2012086760A1 (en) Disinfectant
Estrela et al. Demetallization of Enterococcus faecalis biofilm: a preliminary study
CN102670648B (en) Liquid iodine disinfectant, preparation method and used container thereof
CN111150705A (en) Alcohol hyaluronic acid disinfectant and preparation method thereof
CN111184658A (en) Hand disinfectant and preparation method thereof
JP6869577B2 (en) Viscous disinfectant
JP6866058B2 (en) Viscous disinfectant
JP2011144146A (en) Gel-like bactericide for finger
JP2786634B2 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210531

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220222

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220323

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220520

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220720

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221114

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230302